Blue Biofuels, Inc. financial data

Symbol
BIOF on OTC
Location
3710 Buckeye St, Suite 120, Palm Beach Gardens, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 23, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.64 % -74.9%
Debt-to-equity -148 % -12.4%
Return On Assets -233 % -1976%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 316M shares +3.29%
Common Stock, Shares, Outstanding 315M shares +2.96%
Entity Public Float 15.8M USD -45.9%
Common Stock, Value, Issued 315K USD +2.96%
Weighted Average Number of Shares Outstanding, Basic 312M shares +2.98%
Weighted Average Number of Shares Outstanding, Diluted 312M shares -1.48%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.33M USD +64%
General and Administrative Expense 2.06M USD +75.1%
Operating Income (Loss) -4.39M USD -69.1%
Nonoperating Income (Expense) 1.02M USD -58.8%
Net Income (Loss) Attributable to Parent -3.38M USD -2410%
Earnings Per Share, Basic 0 USD/shares -167%
Earnings Per Share, Diluted 0 USD/shares -167%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.2K USD -36.3%
Assets, Current 107K USD -50.7%
Property, Plant and Equipment, Net 585K USD +17.5%
Operating Lease, Right-of-Use Asset 385K USD -16.4%
Assets 1.49M USD -0.19%
Liabilities, Current 2.39M USD +22.2%
Operating Lease, Liability, Noncurrent 314K USD -19.6%
Liabilities 4.54M USD +13.6%
Retained Earnings (Accumulated Deficit) -58.8M USD -6.09%
Stockholders' Equity Attributable to Parent -3.06M USD -21.7%
Liabilities and Equity 1.49M USD -0.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.4K USD
Net Cash Provided by (Used in) Financing Activities 100K USD -61.5%
Net Cash Provided by (Used in) Investing Activities -155K USD -643%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 315M shares +2.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -41.2K USD -147%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 95.2K USD -36.3%
Deferred Tax Assets, Valuation Allowance 13.3M USD +2.82%
Deferred Tax Assets, Gross 13.3M USD +2.82%
Operating Lease, Liability 441K USD +413%
Depreciation 29.9K USD +0.39%
Payments to Acquire Property, Plant, and Equipment 105K USD
Lessee, Operating Lease, Liability, to be Paid 480K USD -17.3%
Property, Plant and Equipment, Gross 1.04M USD +25%
Operating Lease, Liability, Current 76.5K USD +9.41%
Lessee, Operating Lease, Liability, to be Paid, Year Two 116K USD +6.09%
Lessee, Operating Lease, Liability, to be Paid, Year One 113K USD +521%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 120K USD +4945%
Lessee, Operating Lease, Liability, to be Paid, Year Three 120K USD +6.09%
Deferred Tax Assets, Operating Loss Carryforwards 13.3M USD +2.82%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102K USD -12%
Additional Paid in Capital 55.5M USD +5.36%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 88.2K USD -69.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%